Advanced search×

Screening for prostate cancer: a review of the evidence for the U.S. Preventive Services Task Force.

Roger R Chou, Jennifer M JM Croswell, Tracy T Dana, Christina C Bougatsos, Ian I Blazina, Rongwei R Fu, Ken K Gleitsmann, Helen C HC Koenig, Clarence C Lam, Ashley A Maltz, J Bruin JB Rugge, and Kenneth K Lin

Ann Intern Med 155(11):762-71 (2011) PMID 21984740

Screening can detect prostate cancer at earlier, asymptomatic stages, when treatments might be more effective.

DOI: 10.1059/0003-4819-155-11-201112060-00375
Version: za2963e q8zad q8zb5 q8zc8 q8zd7 q8zec q8zf2 q8zg8

Similar articles you may find interesting…

  1. A systematic review of evidence for psychological treatments in eating disorders: 2005-2012
    Phillipa Hay

    Int J Eat Disord 46(5):462-469 (2013)

  2. Prevalence of vitamin D insufficiency in survivors of childhood cancer
    Abha Choudhary, Joanne Chou, and Charles Sklar

    Pediatr Blood Cancer 60(7):1237-1239 (2013) PMID 23192881

    The prevalence of 25-OH D insufficiency in these cancer survivors was high but similar to what has been described in the general population. No cancer specific variables were associated with 25-OH D insufficiency. Since cancer survivors are at a higher risk for subsequent malignancies, cardiovascula...
  3. Status report from ‘double agent HLA’: Health and disease
    Philip Dyer, Roger McGilvray, and David Turner

    Mol Immunol 55(1):2-7 (2013) PMID 23046976

    The human major histocompatibility complex is a multi-gene ∼4Mb of DNA including the highly polymorphic HLA genes which are fundamental in effecting a healthy immune response. Detailed knowledge of the structure and function of HLA genes and their alleles and HLA proteins and their...